Abstract PURPOSE: Attempts to improve outcomes of patients with Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) metastatic to bone/bone marrow (BM) have focused on chemotherapy dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback